Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


06.06.2022

4 BMJ
8 Clin Infect Dis
2 J Infect Dis
1 J Pediatr
1 J Virol
2 JAMA
2 MMWR Morb Mortal Wkly Rep
1 PLoS Biol
4 PLoS One
1 Proc Natl Acad Sci U S A
26 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. STOKEL-WALKER C
    How are vaccines being adapted to meet the changing face of SARS-CoV-2?
    BMJ. 2022;377:o1257.
    PubMed        

  2. MAHASE E
    Monkeypox: Healthcare workers will be offered smallpox vaccine as UK buys 20 000 doses.
    BMJ. 2022;377:o1379.
    PubMed        

  3. AU WY, Cheung PP
    Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis.
    BMJ. 2022;377:e069989.
    PubMed         Abstract available

  4. BRYCE E, Ong S
    Covid-19 and mRNA technology are helping Africa fix its vaccine problems.
    BMJ. 2022;377:o1196.
    PubMed        


    Clin Infect Dis

  5. BRUXVOORT KJ, Lewnard JA, Chen LH, Tseng HF, et al
    Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California.
    Clin Infect Dis. 2022 Jun 1. pii: 6596517. doi: 10.1093.
    PubMed         Abstract available

  6. HAVERS FP, Skoff TH, Rench MA, Epperson M, et al
    Maternal Tdap Vaccination during Pregnancy: Impact on Infant Anti-pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
    Clin Infect Dis. 2022 Jun 1. pii: 6596516. doi: 10.1093.
    PubMed         Abstract available

  7. ISHOLA D
    Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
    Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
    PubMed         Abstract available

  8. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    PubMed         Abstract available

  9. PATEL SS, Rauscher M, Kudela M, Pang H, et al
    Clinical Safety Experience of TAK-003 for Dengue Fever: a new Tetravalent Live Attenuated Vaccine Candidate.
    Clin Infect Dis. 2022 May 26. pii: 6593313. doi: 10.1093.
    PubMed         Abstract available

  10. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    PubMed         Abstract available

  11. ANGLEMYER A, McNeill A, DuBray K, Sonder GJB, et al
    Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.
    Clin Infect Dis. 2022;74:1859-1861.
    PubMed         Abstract available

  12. MEIRING S, Tempia S, Dominic EM, de Gouveia L, et al
    Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003-2018.
    Clin Infect Dis. 2022;74:1729-1735.
    PubMed         Abstract available


    J Infect Dis

  13. OSTER G, Bornheimer R, Ottino K
    Letter to the Editor in Response to Hall EW, Weng MK, Harris AM, et al. Assessing the Cost-Utility of Universal Hepatitis B Vaccination Among Adults.
    J Infect Dis. 2022 May 26. pii: 6593317. doi: 10.1093.
    PubMed        

  14. ROSTAD CA, Chen X, Sun HY, Hussaini L, et al
    Functional antibody responses to SARS-CoV-2 variants in children with COVID-19, MIS-C, and after two doses of BNT162b2 vaccination.
    J Infect Dis. 2022 May 26. pii: 6593309. doi: 10.1093.
    PubMed         Abstract available


    J Pediatr

  15. SPICER KB, Glick C, Cavanaugh AM, Thoroughman D, et al
    Association of SARS-CoV-2 Vaccination or a Prior Positive Test Result in Adolescents during the Delta Variant Surge in Kentucky.
    J Pediatr. 2022 May 26. pii: S0022-3476(22)00486.
    PubMed         Abstract available


    J Virol

  16. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    PubMed         Abstract available


    JAMA

  17. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
    PubMed        

  18. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  19. RAO AK, Petersen BW, Whitehill F, Razeq JH, et al
    Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 202
    MMWR Morb Mortal Wkly Rep. 2022;71:734-742.
    PubMed         Abstract available

  20. SAPKOTA S, Caruso E, Kobau R, Radhakrishnan L, et al
    Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:703-708.
    PubMed         Abstract available


    PLoS Biol

  21. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
    Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
    PLoS Biol. 2022;20:e3001643.
    PubMed         Abstract available


    PLoS One

  22. AHIAKPA JK, Cosmas NT, Anyiam FE, Enalume KO, et al
    COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans.
    PLoS One. 2022;17:e0268230.
    PubMed         Abstract available

  23. PILTCH-LOEB R, Silver DR, Kim Y, Norris H, et al
    Determinants of the COVID-19 vaccine hesitancy spectrum.
    PLoS One. 2022;17:e0267734.
    PubMed         Abstract available

  24. ROGERS BG, Tao J, Almonte A, Toma E, et al
    Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island.
    PLoS One. 2022;17:e0268587.
    PubMed         Abstract available

  25. GEBRETNSAE H, Hadgu T, Ayele B, Gebre-Egziabher E, et al
    Knowledge of vaccine handlers and status of cold chain and vaccine management in primary health care facilities of Tigray region, Northern Ethiopia: Institutional based cross-sectional study.
    PLoS One. 2022;17:e0269183.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  26. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al
    Simulating COVID-19 classroom transmission on a university campus.
    Proc Natl Acad Sci U S A. 2022;119:e2116165119.
    PubMed         Abstract available


    Vaccine

  27. MOUSSAOUI S, Combes S, Ibanez G, Gautier A, et al
    Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study.
    Vaccine. 2022 May 26. pii: S0264-410X(22)00636.
    PubMed         Abstract available

  28. ILESANMI MM, Adeyinka DA, Olakunde BO
    Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
    Vaccine. 2022 May 26. pii: S0264-410X(22)00632.
    PubMed         Abstract available

  29. LARSEN L, Bistrup C, Sorensen SS, Boesby L, et al
    Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded, randomized clinical trial.
    Vaccine. 2022 May 26. pii: S0264-410X(22)00635.
    PubMed         Abstract available

  30. TAFURI S, Bianchi FP, Stefanizzi P
    The public health and the question of the "best vaccine".
    Vaccine. 2022 May 26. pii: S0264-410X(22)00639.
    PubMed        

  31. HOFFMAN BL, Batra Hershey T, Chu KH, Sidani JE, et al
    Moving vaccination beyond partisan politics.
    Vaccine. 2022 May 26. pii: S0264-410X(22)00664.
    PubMed        

  32. ZHOU Y, Hu X, Chen R, Wu J, et al
    Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines.
    Vaccine. 2022 May 26. pii: S0264-410X(22)00620.
    PubMed         Abstract available

  33. QUINN MK, Edmond KM, Fawzi WW, Hurt L, et al
    Non-specific effects of BCG and DTP vaccination on infant mortality: An analysis of birth cohorts in Ghana and Tanzania.
    Vaccine. 2022 May 23. pii: S0264-410X(22)00536.
    PubMed         Abstract available

  34. MALTER KB, Tugel ME, Gil-Rodriguez M, de la Guardia G, et al
    Corrigendum to "Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States" [Vaccine 40(7) (2022) 1001-1009].
    Vaccine. 2022 May 23. pii: S0264-410X(22)00619.
    PubMed        

  35. BECK E, Biundo E, Devlin N, Doherty TM, et al
    Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.
    Vaccine. 2022 May 23. pii: S0264-410X(22)00490.
    PubMed         Abstract available

  36. REES F, Geiger M, Lilleholt L, Zettler I, et al
    Measuring parents' readiness to vaccinate themselves and their children against COVID-19.
    Vaccine. 2022 May 5. pii: S0264-410X(22)00549.
    PubMed         Abstract available

  37. GAGHAN C, Adams D, Mohammed J, Crespo R, et al
    Characterization of vaccine-induced immune responses against coccidiosis in broiler chickens.
    Vaccine. 2022 May 25. pii: S0264-410X(22)00638.
    PubMed         Abstract available

  38. LAI X, Li M, Hou Z, Guo J, et al
    Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.
    Vaccine. 2022 May 27. pii: S0264-410X(22)00606.
    PubMed         Abstract available

  39. SAVULESCU C, Krizova P, Valentiner-Branth P, Ladhani S, et al
    Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
    Vaccine. 2022 May 27. pii: S0264-410X(22)00581.
    PubMed         Abstract available

  40. DUBE E, Gagnon D, MacDonald N
    Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.
    Vaccine. 2022 May 25. pii: S0264-410X(22)00670.
    PubMed        

  41. MACDONALD NE, Dube E, Comeau JL
    Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework.
    Vaccine. 2022 May 27. pii: S0264-410X(22)00669.
    PubMed        

  42. RODES-SANCHEZ M, Spencer J, Tantri A, Mitrovich R, et al
    Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking.
    Vaccine. 2022 May 27. pii: S0264-410X(22)00671.
    PubMed        

  43. SHIOHARA M, Suzuki S, Shichinohe S, Ishigaki H, et al
    Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
    Vaccine. 2022 May 28. pii: S0264-410X(22)00640.
    PubMed         Abstract available

  44. SHAPIRO BEN DAVID S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, et al
    Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
    Vaccine. 2022 May 28. pii: S0264-410X(22)00668.
    PubMed         Abstract available

  45. KLEINWAKS G, Schmit V, Morrison J
    Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174].
    Vaccine. 2022 May 28. pii: S0264-410X(22)00675.
    PubMed        

  46. HEMMING-HARLO M, Gylling A, Herse F, Haavisto I, et al
    Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
    Vaccine. 2022 May 28. pii: S0264-410X(22)00584.
    PubMed         Abstract available

  47. CHONG-VALBUENA A, De-Jesus-Maria I, Agurto-Ramirez A, Puchades-Gimeno F, et al
    Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naive and previously infected by SARS-CoV-2.
    Vaccine. 2022 May 12. pii: S0264-410X(22)00586.
    PubMed         Abstract available

  48. SZANYI J, Wilson T, Scott N, Blakely T, et al
    A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
    Vaccine. 2022 May 20. pii: S0264-410X(22)00634.
    PubMed         Abstract available

  49. JANKO MM, Joffe J, Michael D, Earl L, et al
    Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
    Vaccine. 2022 May 25. pii: S0264-410X(22)00637.
    PubMed         Abstract available

  50. VUICHARD-GYSIN D, Schoenenberger A
    Detection of a potential error in the results of the manuscript "Dementia risk following influenza vaccination in a large veteran cohort" that could eventually call into question the main conclusion.
    Vaccine. 2022;40:3528.
    PubMed        

  51. WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
    In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.
    Vaccine. 2022;40:3529.
    PubMed        

  52. HEININGER U
    Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23):3120-3130.
    Vaccine. 2022;40:3530.
    PubMed        


    Virus Res

  53. JUNG MH, Nikapitiya C, Kim SJ, Han HJ, et al
    Protective immunity induced by ankyrin repeat-containing protein-based DNA vaccine against rock bream iridovirus (RBIV) in rock bream (Oplegnathus fasciatus).
    Virus Res. 2022 May 26:198827. doi: 10.1016/j.virusres.2022.198827.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: